🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementAlopecia on GLP-1 — need advice Page 3

Alopecia on GLP-1 — need advice

josh_phd_bmore Sun, Mar 15, 2026 at 2:56 PM 29 replies 1,080 viewsPage 3 of 6
DanielChem_CHI
Senior Member
1,234
5,678
Mar 2024
Chicago, IL
Mar 17, 2026 at 10:46 PM#11
TinaHashiRN said:
There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

That is right, and it stops being right at the edges. The general case is well behaved; the interesting cases in this thread are all at the boundary where the general case breaks.

10 8fiona_VT, denise_HTX, raj_cambridge and 7 others
Reply Quote Save Share Report
A1cHero_PHX
Member
523
2,678
Jul 2024
Phoenix, AZ
Mar 19, 2026 at 10:50 AM#12
wanda_boise said:
Agreed, with the usual condition: that holds for the average and this board is a collection of individuals.

Genuinely useful, thank you. I had the facts and not the framework. I will report back once I have actually tried it.

11 9KarenAZ_mom, zoe_NC, Dr.ObesityLA and 8 others
Reply Quote Save Share Report
KarenAZ_mom
Member
567
2,567
Aug 2024
Scottsdale, AZ
Mar 20, 2026 at 10:52 PM#13
TinaHashiRN said:
There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

Careful with the causal language. Two things moving together in a period when five things changed is not a mechanism, and stating it as one makes the thread less useful to somebody reading it later.

12 10bri_stats, pete_manc_UK, anna.melb_AU and 9 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
DoseLogDan
Member
201
567
Feb 2025
Montana
Mar 22, 2026 at 10:54 AM#14

One concrete data point for the thread. The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the same conditions. Nobody wants that answer and it is still the answer.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

13 11sophie_paris, mel_PDX, Dr.AddMedPHL and 10 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Mar 23, 2026 at 10:55 PM#15

Moderator note: the sourcing question belongs in the vendor section and has been split out. No action needed from anybody.

14 12PurityPaulOR, MaxMetOK, MounjBrad and 11 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register